- Home
- / Zenopharm
Zenopharm
Total Funding
$18.3 M
Zenopharm Summary
Company Summary
- Overview
- Zenopharm is a pharmaceutical company developing therapeutic solutions for the treatment of breast cancer. It offers ZB716, an oral selective estrogen receptor degrader (SERD), designed for breast cancer patients with metastatic disease.
- Type
- Private
- Status
- Active
- Founded
- 2012
- Website
- http://zenopharm.com
- Cybersecurity rating
Table of Contents
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026